NCT02382198View on ClinicalTrials.gov

Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease

PHASE2UnknownINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

December 31, 2018

Conditions
SialorrheaParkinson's Disease
Interventions
DRUG

Glycopyrrolate

Drug to reduce drooling in patients with Parkinson's Decease.

DRUG

Placebo

Trial Locations (2)

K1Y 4E9

RECRUITING

The Ottawa Hospital - Civic Campus, Ottawa

M5T 2S8

RECRUITING

Toronto Western Hospital, Toronto

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER